Even the “in field” effects of radiation have been shown to be dependent on the immune system, as CD8+ T cells and type I interferon are required for tumor regression after radiation therapy, since their depletion abrogates tumor control after RT (75, 83, 106–108). Here, CD8A is linked to neoplasm.